Percutaneous microwave ablation for primary hepatic carcinoma

doi:10.3877/cma.j.issn.2095-2015.2017.04.004

Abstract

Abstract:

Objective

To investigate the effects for the survival in the patients withprimary hepatic carcinoma(PHC)treated with percutaneous microwave ablation(PMWA).

Methods

From December 2008 to October 2012, 62 cases of PHC were treated by percutaneous microwave ablation.Complete ablation rate, AFP, local recurrence rate, 3-year overall survival rateand complication were analyzed.

Results

A total of 95microwave ablation treatments were performed.Of the 62 patients, the complete ablation rate was 99.4%.The AFP reduce obviously compared to pre-treatment(P=0.02). The 3-year overall survival rate was 79%(49/62), local recurrence rate was 6.1%(11/180)and serious complications after operations rate was 3.2%(2/62)respectively.

Conclusion

Percutaneous microwave ablation is aefficient and safe therapy for PHC.

Key words: primary hepatic carcinoma, microwave ablation, treatment outcome

Kai Wang, Yuqin Tian, Haiwen Zhang. Percutaneous microwave ablation for primary hepatic carcinoma[J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2017, 07(04): 159-162.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhxhbyyxzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-2015.2017.04.004

https://zhxhbyyxzz.cma-cmc.com.cn/EN/Y2017/V07/I04/159

Figures/Tables 4

References 15

1	Tsai, S.and T. M.Pawlik, Outcomes of Ablation Versus Resection for Colorectal Liver Metastases: Are We Comparing Apples with Oranges? Annals of Surgical Oncology, 2009.16(9): p.2422-2428.
2	Dong, B, et al.Percutaneous sonographically guided microwave coagulation therapy for hepatocellular carcinoma: results in 234 patients.AJR Am J Roentgenol, 2003.180(6): p.1547-55.
3	原发性肝癌诊疗规范(2011年版)．临床肝胆病杂志，2011(11)：第1141-1159页．
4	庄兴俊等，影像引导下经皮微波局部消融治疗原发性肝癌疗效观察．中华消化病与影像杂志(电子版)，2013.6(3)：第147-149页．
5	陈敏山等，原发性肝癌局部消融治疗的专家共识．临床肿瘤学杂志，2011(01)：第70-73页．
6	Villanueva, A, V.Hernandez-Gea and J. M.Llovet.Medical therapies for hepatocellular carcinoma: a critical view of the evidence.Nat Rev Gastroenterol Hepatol, 2013.10(1): p.34-42.
7	Takayasu, K, et al.Overall survival after transarterial lipiodol infusion chemotherapy with or without embolization for unresectable hepatocellular carcinoma: propensity score analysis.AJR Am J Roentgenol, 2010.194(3): p.830-7.
8	Medhat, E, et al.Value of microwave ablation in treatment of large lesions of hepatocellular carcinoma.Journal of Digestive Diseases, 2015.16(8): p.456-463.
9	Shi, J, et al.Comparison of microwave ablation and surgical resection for treatment of hepatocellular carcinomas conforming to Milan criteria.Journal of Gastroenterology and Hepatology, 2014.29(7): p.1500-1507.
10	黎升等，经皮微波消融与肝切除治疗肝细胞肝癌的疗效比较．中华肿瘤杂志，2015(4)：第301-307页．
11	刘锦新，肝动脉化疗栓塞联合微波消融治疗肝细胞癌的研究．微创医学，2010(04)：第333-335页．
12	Zhuang, X,et al., Effects of combining transarterial chemoembolization with percutaneous microwave coagulation therapy for hepatocellular carcinoma abutting the diaphragm.Minim Invasive Ther Allied Technol, 2016.25(2): p.107-12.
13	Bilchik A.J, et al.Cryosurgical ablation and radiofrequency ablation for unresectable hepatic malignant neoplasms: a proposed algorithm.Arch Surg, 2000.135(6): p.657-62；discussion 662-4.
14	Zhang N.N, et al.High-powered microwave ablation of larger hepatocellular carcinoma: evaluation of recurrence rate and factors related to recurrence.Clinical Radiology, 2015.70(11): p.1237-1243.
15	Livraghi, T , et al.Complications of Microwave Ablation for Liver Tumors: Results of a Multicenter Study.CardioVascular and Interventional Radiology, 2012.35(4): p.868-874.

男/女(例)	53/9
年龄(岁)	37-76
乙肝/丙肝/其他肝炎(例)	54/4/0
肿瘤直径(cm)	0.8～15.0
AFP：>200 μg/L/13.6～200 μg/L/正常(例)	24/9/29
术前肝功能Child-pugh分级：A级/B级(例)	60/2
ECOG评分：1分(例)	62/0

男/女(例)	53/9
年龄(岁)	37-76
乙肝/丙肝/其他肝炎(例)	54/4/0
肿瘤直径(cm)	0.8～15.0
AFP：>200 μg/L/13.6～200 μg/L/正常(例)	24/9/29
术前肝功能Child-pugh分级：A级/B级(例)	60/2
ECOG评分：1分(例)	62/0

类型	例数	病灶数
小肝癌(0～3 cm)	34	122
中肝癌(3～5 cm)	24	51
大肝癌(5～10 cm)	3	6
巨块型肝癌(>10 cm)	1	1

类型	例数	病灶数
小肝癌(0～3 cm)	34	122
中肝癌(3～5 cm)	24	51
大肝癌(5～10 cm)	3	6
巨块型肝癌(>10 cm)	1	1

并发症	例次	恢复时间(d)
发热	8	2～4
轻中度上腹痛	11	3～5
恶心、呕吐	1	1
中量胸腔积液	1	45
消化道穿孔	2	20
转氨酶升高(<2.5倍正常值)	26	5～14
血小板降低(60～100×10⁹/L)	8	6～10

Please choose a citation manager

Content to export